KR20050027995A - 경피적 조제물용 플랫폼(ptf) - Google Patents

경피적 조제물용 플랫폼(ptf) Download PDF

Info

Publication number
KR20050027995A
KR20050027995A KR1020047021277A KR20047021277A KR20050027995A KR 20050027995 A KR20050027995 A KR 20050027995A KR 1020047021277 A KR1020047021277 A KR 1020047021277A KR 20047021277 A KR20047021277 A KR 20047021277A KR 20050027995 A KR20050027995 A KR 20050027995A
Authority
KR
South Korea
Prior art keywords
composition
transdermal administration
oil emulsion
percutaneous
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020047021277A
Other languages
English (en)
Korean (ko)
Inventor
유발 심하 랜드샤프트
Original Assignee
홀덴 디벨럽먼트 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 홀덴 디벨럽먼트 리미티드 filed Critical 홀덴 디벨럽먼트 리미티드
Publication of KR20050027995A publication Critical patent/KR20050027995A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020047021277A 2002-06-27 2003-06-21 경피적 조제물용 플랫폼(ptf) Withdrawn KR20050027995A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10228680.9 2002-06-27
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)

Publications (1)

Publication Number Publication Date
KR20050027995A true KR20050027995A (ko) 2005-03-21

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047021277A Withdrawn KR20050027995A (ko) 2002-06-27 2003-06-21 경피적 조제물용 플랫폼(ptf)

Country Status (14)

Country Link
US (1) US20050118241A1 (cg-RX-API-DMAC7.html)
EP (1) EP1515706A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005535635A (cg-RX-API-DMAC7.html)
KR (1) KR20050027995A (cg-RX-API-DMAC7.html)
CN (1) CN1665492A (cg-RX-API-DMAC7.html)
AR (1) AR040287A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003252459A1 (cg-RX-API-DMAC7.html)
CA (1) CA2490022A1 (cg-RX-API-DMAC7.html)
DE (1) DE10228680A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012732A (cg-RX-API-DMAC7.html)
MY (1) MY157852A (cg-RX-API-DMAC7.html)
TW (1) TW200500093A (cg-RX-API-DMAC7.html)
WO (1) WO2004002444A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200500710B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20120283332A1 (en) * 2009-05-12 2012-11-08 Ohio University Transdermal delivery of metformin
US10363229B2 (en) 2009-06-05 2019-07-30 Joan McInyre Caron Methods and compositions for the treatment of cancer
RU2659729C2 (ru) * 2012-07-30 2018-07-03 Матинас Биофарма Нанотекнолоджис, Инк. Кохлеаты, полученные с использованием фосфатидилсерина сои

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
DE69216836T2 (de) * 1991-07-26 1997-06-12 Smithkline Beecham Corp W/o mikroemulsionen
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
WO1996010439A1 (en) * 1994-09-30 1996-04-11 Kabushiki Kaisya Advance Interface for iontophoretic percutaneous administration, and agent and method for treating the skin for that purpose
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
JP2002519366A (ja) * 1998-07-07 2002-07-02 トランスダーマル・テクノロジーズ・インコーポレーテツド 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達
CA2369594A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Also Published As

Publication number Publication date
WO2004002444A2 (en) 2004-01-08
CN1665492A (zh) 2005-09-07
TW200500093A (en) 2005-01-01
WO2004002444A3 (en) 2004-03-11
ZA200500710B (en) 2005-09-05
AR040287A1 (es) 2005-03-23
US20050118241A1 (en) 2005-06-02
MY157852A (en) 2016-07-29
CA2490022A1 (en) 2004-01-08
JP2005535635A (ja) 2005-11-24
MXPA04012732A (es) 2005-11-17
EP1515706A2 (en) 2005-03-23
AU2003252459A1 (en) 2004-01-19
DE10228680A1 (de) 2004-01-22

Similar Documents

Publication Publication Date Title
US6274166B1 (en) Transdermal delivery system
Brown et al. Transdermal delivery of drugs
AU2003238862B2 (en) Formulations for amylin agonist peptides
US5514673A (en) Pharmaceutical composition containing lipophilic drugs
US5574006A (en) Nasally administrable peptide compositions on hydroxyapatite carriers
TWI685348B (zh) 速效胰島素組合物
RU2198677C2 (ru) Фармацевтическая композиция для пероральной доставки физиологически активного пептидного агента и способ усиления его биодоступности
KR960001373B1 (ko) 제약학적 활성 물질의 침투 증강용 2성분계 침투증강 조성물
US7033998B2 (en) Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
Tengamnuay et al. Bile salt–fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa
US20050118241A1 (en) Platform for transdermal formulations (ptf)
Fransson et al. Transdermal absorption of a liposomeencapsulated formulation of lidocaine following topical administration in cats
SK9062000A3 (en) Transmucosal formulations of levosimendan
US7291591B2 (en) Alcohol-free transdermal insulin composition
JP3263598B2 (ja) 経鼻吸収用生理活性ペプチド組成物
US6667052B2 (en) Transdermal delivery system
EA002023B1 (ru) Фармацевтическая композиция местного применения для введения в живой организм, содержащая пептидное лекарственное средство
Vachhal et al. Transdermal patches: updated review as a novel drug delivery system
Patel et al. A Comprehensive Review Article on Transdermal Patch
JP2734554B2 (ja) インスリン様成長因子iの点鼻用液剤
CH660689A5 (fr) Medicament pour traiter les etats hypotrophiques.
Thassu et al. Controlled transdermal mucolytic delivery system: in vivo performance
TAMAKI et al. Intestinal Absorption of a New Anticholinergic Agent, Timepidium Bromide. II. Enhancement of Absorption
Umbreen et al. IMPRACTICALITY EXAMINATION FOR TRANSDERMAL TRANSFER OF ELVITEGRAVIR INTERPRETATIONS
JPH03128327A (ja) モチリン製剤

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20041227

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid